Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Stopped Enrollment was much slower than anticipated, leading to a decision to terminate the study early for enrollment futility.

Conditions

• Diabetes Mellitus

Interventions

• DRUG: placebo
• DRUG: exenatide

Sponsor

AstraZeneca

Collaborators

• [object Object]